Steve Harr - CFO & Head, Juno Therapeutics, Inc

As of March 7, 2018


Steve Harr Net Worth

  • Net worth is estimated to be at least $245.12M
  • Owns at least 763,332 units of Juno Therapeutics, Inc stock
  • Sold an estimated value of $52.53M in the last 3 years at Juno Therapeutics, Inc

Steve Harr Trading

  • Largest purchase of shares was 8,750 units , worth over $76.3K on December 22, 2017
  • Largest sale of shares was 35,000 units , worth over $1.63M on December 11, 2015
  • In total has made about 15 transactions over 3 years
  • Usually trades in March, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Steve Harr Mailing Address

  • Mailing address is 307 Westlake Ave. North, Ste. 300 Seattle WA 98109 WA

Juno Therapeutics, Inc Insider Trading

  • The most recent transaction was 4,157 units sold on February 14, 2018 by Robert Azelby worth over $355.63K
  • In the last 3 years, insiders at Juno Therapeutics, Inc sold an estimated value of $1.97B and bought an estimated value of $11.52M
  • The most active traders are Richard Klausner, Director,  Anthony Evnin, Director,  and Bernard Cassidy, General Counsel & Secretary
  • Insider trading is most common in June, with the busiest year in 2017

Juno Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1